ritmo < rituximab < rmds

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 113.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000000 (2009)	Susan P. Bruce [États-Unis]	Recent Developments in the Treatment of Rheumatoid Arthritis
000024 (2012)	A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France]	Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?
000026 (2016)	Young Ho Lee [Corée du Sud] ; Sang-Cheol Bae [Corée du Sud]	Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta‐analysis of randomized controlled trials
000038 (2016)	Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]	Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study
000041 (2014)	P. Jayasekera [Royaume-Uni] ; R. Parslew [Royaume-Uni] ; A. Al-Sharqi [Royaume-Uni]	A case of tumour necrosis factor‐α inhibitor‐ and rituximab‐induced plantar pustular psoriasis that completely resolved with tocilizumab
000073 (2013)	Györgyi M Zes [Hongrie] ; Ferenc Sipos [Hongrie] ; Judit Csomor [Hongrie] ; Lídia Sréter [Hongrie]	Successful tocilizumab treatment in a patient with human herpesvirus 8‐positive and human immunodeficiency virus‐negative multicentric Castleman's disease of plasma cell type nonresponsive to rituximab‐CVP therapy
000088 (2011)	Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis]	Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach
000098 (2012)	H.-I. Huppertz [Allemagne]	Biologika bei Kindern und Jugendlichen zur Behandlung rheumatischer Erkrankungen
000099 (2010)	Chi Chiu Mok [Hong Kong] ; Lai Shan Tam [Hong Kong] ; Tak Hin Chan [Hong Kong] ; Gavin K. W. Lee [Hong Kong] ; Edmund K. M. Li [Hong Kong]	Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology
000113 (2005)	Josef S. Smolen [Autriche] ; Kurt Redlich [Autriche] ; Jochen Zwerina [Autriche] ; Daniel Aletaha [Autriche] ; Günter Steiner [Autriche] ; Georg Schett [Autriche]	Pro-inflammatory cytokines in rheumatoid arthritis
000117 (2010)	C. B. Confavreux [France] ; R. D. Chapurlat [France]	Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
000130 (2007)	Gerald Gartlehner [Autriche, États-Unis] ; Richard A. Hansen [États-Unis] ; Beth L. Jonas [États-Unis] ; Patricia Thieda [États-Unis] ; Kathleen N. Lohr [États-Unis]	Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
000149 (2010)	J. Wollenhaupt [Allemagne] ; K. Krüger [Allemagne]	Nicht-TNF-Biologika in der Therapiestrategie bei rheumatoider Arthritis
000150 (2012)	O. Psenak [Autriche] ; A. Studnicka-Benke [Autriche] ; R. Greil [Autriche]	Sicherheit der Immunsuppressiva
000151 (2012)	I. Kötter [Allemagne]	Update Morbus Behçet
000161 (2013)	I. Kötter [Allemagne] ; J. C. Henes [Allemagne]	Etablierte Medikamente
000194 (2007)	M. Schneider [Allemagne]	Exploring new territory: considering the future
000203 (2011)	K. Krüger [Allemagne]	Kombinationsbehandlung von Methotrexat mit DMARDs oder Biologika – Aktueller Stand
000211 (2006)	Lyndell Lim [États-Unis] ; Eric B. Suhler [États-Unis] ; Justine R. Smith [États-Unis]	Biologic therapies for inflammatory eye disease
000227 (2006)	Marcus D. Köller [Autriche]	Targeted therapy in rheumatoid arthritis
000239 (2012)	S. Kleinert [Allemagne] ; H. P. Tony [Allemagne]	Rheumatische Erkrankungen mit Erstmanifestation im mittleren Lebensalter

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "rituximab" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "rituximab" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    rituximab
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021